Valuation: Cegedim

Market Cap 139M 158M 130M 119M 224M 15.19B 226M 1.54B 602M 7.5B 595M 582M 25.92B P/E 2026 *
6.65x
P/E 2027 * 5.07x
Enterprise Value 301M 343M 281M 258M 484M 32.88B 490M 3.33B 1.3B 16.23B 1.29B 1.26B 56.11B EV / Sales 2026 *
0.46x
EV / Sales 2027 * 0.4x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 day+0.59%
1 week+0.99%
Current month-4.67%
1 month-6.08%
3 months-12.45%
6 months-25.82%
Current year-24.72%
1 week 9.95
Extreme 9.95
10.42
1 month 9.95
Extreme 9.95
11.18
Current year 8.5
Extreme 8.5
15.3
1 year 8.5
Extreme 8.5
15.3
3 years 8.5
Extreme 8.5
21.8
5 years 8.5
Extreme 8.5
29.8
10 years 8.5
Extreme 8.5
44.5
Manager TitleAgeSince
Chief Executive Officer 83 25/10/2009
Director of Finance/CFO - 14/06/2016
Corporate Officer/Principal 55 26/11/2015
Director TitleAgeSince
Chairman 83 25/10/2009
Director/Board Member 72 09/08/2010
Director/Board Member 55 26/10/2009
Date Insider Type Main position Quantity % Market Cap.
4/28/26 A Buy 74,537 0.5287%
4/16/26 A Buy 500 0.0035%
4/1/26 A Buy 1,239 0.0088%
Change 5-day change 1-year change 3-year change Capi.($)
+0.59%+0.99%-0.49%-53.21% 158M
+0.40%-5.39%-51.48%+3.63% 345B
+5.26%+16.73%-34.75%+28.86% 199B
+3.82%+7.82%-44.18%-3.40% 109B
+5.73%+12.54%-38.21%+7.42% 42.61B
-1.07%-3.99%-75.76%+125.21% 35.43B
+8.28%+12.44%-8.83%+67.28% 29.7B
+5.09%+6.75%-33.74%+50.09% 17.88B
+3.43%+11.51%-32.03%+8.95% 13B
+5.57%+10.54%-30.66%+91.27% 12.43B
Average +3.59%+1.91%-35.01%+32.61% 80.43B
Weighted average by Cap. +2.56%+2.19%-44.11%+19.27%

Financials

2026 *2027 *
Net sales 660M 750M 614M 564M 1.06B 71.95B 1.07B 7.3B 2.85B 35.53B 2.82B 2.76B 123B 684M 778M 637M 585M 1.1B 74.62B 1.11B 7.57B 2.96B 36.85B 2.92B 2.86B 127B
Net income 21.3M 24.23M 19.83M 18.21M 34.19M 2.32B 34.64M 236M 92.05M 1.15B 90.95M 88.99M 3.97B 28M 31.85M 26.06M 23.94M 44.95M 3.05B 45.54M 310M 121M 1.51B 120M 117M 5.21B
Net Debt 162M 184M 151M 139M 260M 17.69B 264M 1.79B 701M 8.73B 692M 677M 30.19B 134M 152M 125M 114M 215M 14.59B 218M 1.48B 578M 7.2B 571M 559M 24.9B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
6,344
Date Price Change Volume
28/07/26 10.20 +0.59% 1,026
27/07/26 €10.14 +0.40% 3,806
24/07/26 €10.10 -1.94% 9,703
23/07/26 €10.30 +1.78% 1,320
22/07/26 €10.12 +0.20% 2,218
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
10.14EUR
Average target price
15.50EUR
Spread / Average Target
+52.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALCGM Stock